From my experiences of having lived and/or traveled in many countries and neighborhoods and of having been exposed to numerous people from virtually every major country/ culture/race/ religion in the world, on a per capita basis, hair loss is of most concern to Asians. When I say Asians, I don’t just mean Chinese, Japanese and Koreans, but also include South Asians (i.e., Bangladeshis, Burmese, Filipinos, Indians, Indonesians, Pakistanis, Thais, Vietnamese etc…) in there. Since 60 percent of all people in the world reside in Asia as defined above, I had to emphasize that on a per capita basis hair loss is of most distress to people in this region.
Reasons for this include the fact that balding rates are much lower in Asians than in Caucasians so one really stands out when losing hair, and the fact that head shaving is not nearly as common and fashionable among Asians as among people of African descent. In annual lists of countries with the most plastic surgery procedures (on a per capita basis), Asian nations such as South Korea and Taiwan always seem to be near the top, and Thailand is renowned for cosmetic procedure related medical tourism.
In any case, it is therefore not surprising that such a significant amount of hair multiplication and hair cloning related research has been coming out of Asia in recent years. The latest is from Taiwan, where the world’s first human hair cloning study/experiment is underway in which around 400 men and women will have their own scalp’s dermal papillae cells cultured in a lab and then implanted into their scalp. The study is being undertaken at the National Taiwan University Hospital. Successful results have already been shown in animals, and it seems like human testing in Taiwan is less restricted than in the US or Western Europe. Hopefully, the results of this study will be positive with no side effects.
The person who is leading this study is Sung-Jan Lin. Some relatively recent hair loss research papers from National Taiwan University and Dr. Lin.
It seems like the study was originally supposed to commence in May 2006 per this clinical trials overview and I am surprised at such a lengthy delay.
Daily Mail has an article on this ground breaking development.